HEMORRHAGIC STROKE IN THE STROKE PREVENTION BY AGGRESSIVE REDUCTION IN CHOLESTEROL LEVELS STUDY
暂无分享,去创建一个
[1] M. Hennerici,et al. Effect of atorvastatin in elderly patients with a recent stroke or transient ischemic attack , 2009, Neurology.
[2] M. Hennerici,et al. Relative Effects of Statin Therapy on Stroke and Cardiovascular Events in Men and Women: Secondary Analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Study , 2008, Stroke.
[3] D. Herrington,et al. Beneficial effects of aggressive low-density lipoprotein cholesterol lowering in women with stable coronary heart disease in the Treating to New Targets (TNT) study , 2007, Heart.
[4] M. Hennerici,et al. High-dose atorvastatin after stroke or transient ischemic attack. , 2006, The New England journal of medicine.
[5] D. Lawlor,et al. Serum cholesterol, haemorrhagic stroke, ischaemic stroke, and myocardial infarction: Korean national health system prospective cohort study , 2006, BMJ : British Medical Journal.
[6] V. Chair,et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the , 2006, Circulation.
[7] A. Algra,et al. Predictors of risk of intracerebral haemorrhage in patients with a history of TIA or minor ischaemic stroke , 2005, Journal of Neurology, Neurosurgery & Psychiatry.
[8] R. Collins,et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins , 2005, The Lancet.
[9] Philip J. Barter,et al. Intensive lipid lowering with atorvastatin in patients with stable coronary disease. , 2005, The New England journal of medicine.
[10] S. Yokoyama,et al. HMG-CoA Reductase Inhibitor Protects Against In Vivo Arterial Thrombosis by Augmenting Platelet-Derived Nitric Oxide Release in Rats , 2005, Journal of cardiovascular pharmacology.
[11] P. Touboul,et al. Statins in Stroke Prevention and Carotid Atherosclerosis: Systematic Review and Up-to-Date Meta-Analysis , 2004, Stroke.
[12] C. Cannon,et al. Pathological Changes in Acute Coronary Syndromes: The Role of Statin Therapy in the Modulation of Inflammation, Endothelial Function and Coagulation , 2004, Journal of Thrombosis and Thrombolysis.
[13] H. Diener,et al. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial , 2004, The Lancet.
[14] Richard M. Moe,et al. Optimal low-density lipoprotein is 50 to 70 mg/dl: lower is better and physiologically normal. , 2004, Journal of the American College of Cardiology.
[15] R. Collins,et al. Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20 536 people with cerebrovascular disease or other high-risk conditions , 2004, The Lancet.
[16] M. Hennerici,et al. Design and Baseline Characteristics of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Study , 2003, Cerebrovascular Diseases.
[17] A. Algra,et al. Risk Factors for Intracerebral Hemorrhage in the General Population: A Systematic Review , 2003, Stroke.
[18] Daniel W. Jones,et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, JAMA.
[19] J. Mehta,et al. Anti-thrombotic Effects of Atorvastatin-An Effect Unrelated to Lipid Lowering , 2002, Journal of cardiovascular pharmacology and therapeutics.
[20] M. Woodward,et al. Randomised trial of a perindopril-based blood pressure lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack , 2001 .
[21] P. Austin,et al. Rate of stroke recurrence in patients with primary intracerebral hemorrhage. , 2000, Stroke.
[22] D. Albanes,et al. Different risk factors for different stroke subtypes: association of blood pressure, cholesterol, and antioxidants. , 1999, Stroke.
[23] S. Ibayashi,et al. Blood pressure control and recurrence of hypertensive brain hemorrhage. , 1998, Stroke.
[24] J. V. van Swieten,et al. Intracerebral hematomas during anticoagulant treatment. , 1990, Stroke.
[25] D. Reed,et al. Serum cholesterol and hemorrhagic stroke in the Honolulu Heart Program. , 1989, Stroke.
[26] D. Jacobs,et al. Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the multiple risk factor intervention trial. , 1989, The New England journal of medicine.